0000914190-13-000789.txt : 20131105 0000914190-13-000789.hdr.sgml : 20131105 20131105163220 ACCESSION NUMBER: 0000914190-13-000789 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131101 FILED AS OF DATE: 20131105 DATE AS OF CHANGE: 20131105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardiovascular Systems Inc CENTRAL INDEX KEY: 0001180145 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411698056 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 651 CAMPUS DRIVE CITY: ST. PAUL STATE: MN ZIP: 55112 BUSINESS PHONE: 651-259-1600 MAIL ADDRESS: STREET 1: 651 CAMPUS DRIVE CITY: ST. PAUL STATE: MN ZIP: 55112 FORMER COMPANY: FORMER CONFORMED NAME: REPLIDYNE INC DATE OF NAME CHANGE: 20020813 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Martin David CENTRAL INDEX KEY: 0001304318 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52082 FILM NUMBER: 131193029 MAIL ADDRESS: STREET 1: 651 CAMPUS DRIVE CITY: ST. PAUL STATE: MN ZIP: 55112 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2013-11-01 0001180145 Cardiovascular Systems Inc CSII 0001304318 Martin David 651 CAMPUS DRIVE ST. PAUL MN 55112 1 1 0 0 President and CEO Common Stock 2013-11-01 4 M 0 4100 8.83 A 358152 D Common Stock 2013-11-01 4 S 0 4100 31.0249 D 354052 D Common Stock 1400 I By child Common Stock 1400 I By child Common Stock 1400 I By child Stock Option (right to buy) 8.83 2013-11-01 4 M 0 4100 0 D 2017-02-14 Common Stock 4100 195900 D Stock Option (right to buy) 7.90 2017-06-11 Common Stock 90580 90580 D Stock Option (right to buy) 12.15 2017-12-11 Common Stock 234395 234395 D Stock Option (right to buy) 8.75 2019-03-01 Common Stock 32350 32350 D The shares were sold pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.00 to $31.11 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Fully exercisable. /s/ Alexander Rosenstein as Attorney-in-Fact for David L. Martin pursuant to Power of Attorney previously filed. 2013-11-05